Jun 2026 (Q2 FY26) — Aug 5, 2026
Figma Q2 FY26 — Accelerated Revenue Growth and AI Monetization
Read the full callFigma earnings: last reported Wed, 5 Aug 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 370 | +48.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -31.7 | −32.5 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -112 | −497.3% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
1Y: $60.82 on 14 Oct 2025 → $22.99. High $63.82 (15 Oct 2025), low $16.84 (25 Jun 2026).
Overview
Call summaries
Figma Q2 FY26 — Accelerated Revenue Growth and AI Monetization
Read the full callFigma Q1 FY26 — AI-driven Revenue Acceleration and Strong Monetization Signals
Read the full callEvery analysed call
Financials
Net profit, year on year: −497% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 199 | 217 | 228 | 250 | 274 | 304 | 333 | 370 |
| Operating profit | -47 | 52 | 40 | 2 | -1,137 | -196 | -137 | -117 |
| Operating margin | −23.8% | 23.8% | 17.4% | 0.8% | −414.6% | −64.4% | −41.2% | −31.7% |
| Other income | 18 | 39 | 7 | 37 | 29 | -9 | -4 | 8 |
| Profit before tax | -29 | 91 | 47 | 39 | -1,107 | -204 | -142 | -110 |
| Tax rate | 47.0% | −7.7% | 4.5% | 27.7% | 0.9% | −10.9% | −0.5% | −2.3% |
| Net profit | -16 | 98 | 45 | 28 | -1,097 | -227 | -142 | -112 |
| EPS ($ per share) | -0.07 | — | 0.04 | 0 | -2.72 | — | -0.27 | -0.21 |
| Line item | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Reserves | — | -193 | -1,443 |
| Total liabilities | — | 469 | 838 |
| Fixed assets | — | 15 | 20 |
| Investments | — | 971 | 1,252 |
| Total assets | — | 1,793 | 2,348 |
| Line item | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Cash from operations | 1,047 | -62 | 251 |
| Cash from investing | -57 | -784 | -371 |
| Cash from financing | 0 | 62 | 43 |
| Net cash flow | 990 | -784 | -77 |
| Capital expenditure | -4 | -2 | -4 |
| Free cash flow | 1,044 | -64 | 246 |
| KPI | Mar 2026 Q1 FY26 | Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|
| Net revenue retention rate ARR > $10,000 | 139%Our net dollar retention rate for paid customers spending more than $10,000 in ARR reached 139%, up 3 percentage points from the prior quarter and our highest level in over 2 years.Source: earnings call transcript | 136%In Q2, net dollar retention rate for paid customers with more than $10,000 in ARR remained strong at 136%, even as we begin to anniversary our pricing and packaging changes from March 2025.Source: earnings call transcript | -3 pt |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
274 filings between Nov 3, 2025 and Oct 5, 2026.
Purchases
$36.54M
3 purchases by 1 insider
Sales
$292.64M
156 sales by 9 insiders
83% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Also filed: 47 other filings, 11 conversions, 1 gift.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Field Dylan | — | $164.23M | May 29, 2026 |
| Rasmussen Kris | — | $64.92M | Aug 4, 2026 |
| Reed Andrew Phillips | $36.54M | — | Feb 23, 2026 |
| Voskanian Shaunt | — | $23.69M | Aug 5, 2026 |
| Melwani Praveer | — | $17.96M | Aug 4, 2026 |
| Mulligan Brendan | — | $17.11M | Oct 5, 2026 |
| Herb Tyler | — | $2.96M | Oct 5, 2026 |
| Rimer Daniel H. | — | $620.6K | Aug 10, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Mulligan Brendan General Counsel and Secretary | Sale 10b5-1 plan | 20,701 | $450.0K |
| Oct 5, 2026 | Herb Tyler Chief Accounting Officer | Sale 10b5-1 plan | 1,418 | $30.7K |
| Oct 1, 2026 | Voskanian Shaunt Chief Revenue Officer | Tax withheld | 8,080 | $169.8K |
| Oct 1, 2026 | Herb Tyler Chief Accounting Officer | Tax withheld | 1,838 | $38.6K |
| Oct 1, 2026 | Mulligan Brendan General Counsel and Secretary | Tax withheld | 9,436 | $198.3K |
| Oct 1, 2026 | Melwani Praveer CFO and Treasurer | Tax withheld | 7,037 | $147.9K |
| Sep 3, 2026 | Mulligan Brendan General Counsel and Secretary | Sale 10b5-1 plan | 64,606 | $1.66M |
| Sep 3, 2026 | Mulligan Brendan General Counsel and Secretary | Sale 10b5-1 plan | 44,500 | $1.17M |
| Sep 3, 2026 | Herb Tyler Chief Accounting Officer | Sale 10b5-1 plan | 1,416 | $37.2K |
| Sep 1, 2026 | Mulligan Brendan General Counsel and Secretary | Tax withheld | 9,435 | $259.4K |
| Sep 1, 2026 | Voskanian Shaunt Chief Revenue Officer | Tax withheld | 8,080 | $222.1K |
| Sep 1, 2026 | Melwani Praveer CFO and Treasurer | Tax withheld | 7,037 | $193.4K |
| Sep 1, 2026 | Herb Tyler Chief Accounting Officer | Tax withheld | 1,838 | $50.5K |
| Aug 28, 2026 | Lilly III John Osborne Director | Other | 330,306 | $0 |
| Aug 28, 2026 | Mulligan Brendan General Counsel and Secretary | Sale 10b5-1 plan | 130,800 | $3.94M |
| Aug 28, 2026 | Lilly III John Osborne Director | Other | 5,460 | $0 |
| Aug 28, 2026 | Mulligan Brendan General Counsel and Secretary | Sale 10b5-1 plan | 80,699 | $2.36M |
| Aug 28, 2026 | Mulligan Brendan General Counsel and Secretary | Sale 10b5-1 plan | 100 | $3.1K |
| Aug 27, 2026 | Herb Tyler Chief Accounting Officer | Sale 10b5-1 plan | 2,000 | $60.0K |
| Aug 27, 2026 | Reed Andrew Phillips Director | Other | 14,533 | $0 |
| Aug 27, 2026 | Reed Andrew Phillips Director | Other | 713,067 | $0 |
| Aug 27, 2026 | Reed Andrew Phillips Director | Other | 58,892 | $0 |
| Aug 27, 2026 | Reed Andrew Phillips Director | Other | 35,223 | $0 |
| Aug 27, 2026 | Reed Andrew Phillips Director | Other | 143,536 | $0 |
| Aug 27, 2026 | Reed Andrew Phillips Director | Other | 2,215,239 | $0 |
| Aug 25, 2026 | Reed Andrew Phillips Director | Other | 2,215,239 | $0 |
| Aug 25, 2026 | Reed Andrew Phillips Director | Other | 713,067 | $0 |
| Aug 25, 2026 | Reed Andrew Phillips Director | Other | 14,533 | $0 |
| Aug 25, 2026 | Reed Andrew Phillips Director | Other | 35,320 | $0 |
| Aug 25, 2026 | Reed Andrew Phillips Director | Other | 143,536 | $0 |
| Aug 25, 2026 | Reed Andrew Phillips Director | Other | 58,892 | $0 |
| Aug 21, 2026 | Herb Tyler Chief Accounting Officer | Sale 10b5-1 plan | 1,840 | $49.9K |
| Aug 11, 2026 | Rimer Daniel H. Director | Other | 2,758,691 | — |
| Aug 11, 2026 | Index Ventures VI (Jersey) LP 10% owner | Other | 55,684 | — |
| Aug 11, 2026 | Index Ventures VI (Jersey) LP 10% owner | Other | 23,150 | — |
| Aug 11, 2026 | Rimer Daniel H. Director | Other | 23,150 | — |
| Aug 11, 2026 | Index Ventures VI (Jersey) LP 10% owner | Other | 2,758,691 | — |
| Aug 11, 2026 | Index Ventures VI (Jersey) LP 10% owner | Other | 703,594 | — |
| Aug 11, 2026 | Rimer Daniel H. Director | Other | 703,594 | — |
| Aug 11, 2026 | Rimer Daniel H. Director | Other | 55,684 | — |
| Aug 10, 2026 | Index Ventures VI (Jersey) LP 10% owner | Sale | 12,475 | $316.7K |
| Aug 10, 2026 | Rimer Daniel H. Director | Sale | 12,475 | $316.7K |
| Aug 7, 2026 | Lilly III John Osborne Director | Other | 406,168 | $0 |
| Aug 7, 2026 | Greylock XIV GP LLC 10% owner | Other | 730,257 | $0 |
| Aug 7, 2026 | Greylock XIV GP LLC 10% owner | Other | 730,257 | $0 |
| Aug 7, 2026 | Lilly III John Osborne Director | Other | 6,825 | $0 |
| Aug 7, 2026 | Greylock XIV GP LLC 10% owner | Other | 13,144,577 | $0 |
| Aug 5, 2026 | Voskanian Shaunt Chief Revenue Officer | Sale 10b5-1 plan | 30,000 | $837.2K |
| Aug 4, 2026 | Rasmussen Kris Former Chief Technology Off. | Sale 10b5-1 plan | 196,397 | $5.01M |
| Aug 4, 2026 | Herb Tyler Chief Accounting Officer | Sale 10b5-1 plan | 709 | $18.4K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow Figma, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading